New treatment method targets cholangiocarcinoma tumors.
Milk-derived nanoparticles enhance delivery of therapies.
Research conducted by Mayo Clinic.
Briefing: Milk-derived nanoparticles may enable physicians to target aggressive bile duct cancer
Strategic angle: Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors using milk-derived nanoparticles.